Hammertoe Market Research Report - Global Forecast till 2027

Global Hammertoe Market Research Report: Information by Type (Rigid and Flexible), Treatment & Diagnosis (Treatment and Diagnosis), End User (Hospitals & Clinics and Physiotherapy & Orthopedic Centers) and Region (North America, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/2828-CR | August 2019 | Region: Global | 104 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

The Global Hammertoe Market is expected to register 10.8% CAGR and reach USD 288.6 Million by 2023.


Hammertoe is a feet-related problem, in which the feet bend permanently. The problem occurs due to an imbalance in ligaments and muscles that hold the toe straight. Hammertoe bends the toe downward instead of keeping it straight. One of the reasons causing hammertoe includes wearing a small size or narrow shoes that bend the toe. Other reasons that can cause hammertoe include vein or muscle damage, rheumatoid arthritis, osteoarthritis, stroke, Charcot–Marie–Tooth disease, and other feet problems. The discomfort and pain caused due to hammertoe can be controlled by changing the footwear. Usually, hammertoe occurs due to wrong selection of shoes that affects toe muscles, but in some cases, this problem may be present by birth itself. The increasing prevalence of arthritis and growing R&D expenditure in the healthcare industry boost market growth. However, factors such as complications and pain associated with surgeries, the risk of infections during surgical treatments and hospital stay, and the lack of awareness are expected to hinder the market growth.


Market Dynamics


Arthritis is a common joint-related problem, which may occur due to osteoporosis and age. Arthritis is one of the reasons causing hammertoe at any age. According to the Centers for Disease Control and Prevention, in February 2018, it was reported that the prevalence of arthritis is increasing with age. It has also been estimated that 54.4 million of the population has been diagnosed with arthritis, in which 23.4 % of women and 18.1% of men had arthritis. It was predicted that 78.4 million people above 18 years are likely to be diagnosed with arthritis by 2040 in the US. Therefore, the increasing prevalence of arthritis among the population will boost the market growth.


Global Hammertoe Market Revenue, by Type, 2017 (USD Million)  Hammertoe Market


Sources: MRFR Analysis


Segmentation


Based on type, the global hammertoe market is divided into rigid type and flexible type. In the case of flexible hammertoe, the joints in the toe can be moved and straightened. Flexible hammertoes can cause pain and irritation and can lead to the development of corns and calluses. It is crucial to treat hammertoes, even if the toe is flexible. According to Andrew Park, Senior Manager at Orthopedics at iDATA Research, a global medical device and pharmaceutical market intelligence firm stated that in 2017, 648,000 hammertoe surgeries were held in the US.


The global hammertoe market, based on treatment & diagnosis, has been divided into treatment and diagnosis. The treatment segment has been further segmented into surgery, implant, and others. The surgery segment has been further sub-segmented into arthroplasty and arthrodesis. The diagnosis segmented is sub-segmented into physical examination, x-rays, and others.


The global hammertoe market, based on end user, is segmented into hospitals & clinics and physiotherapy & orthopedic centers. The hospitals & clinics segment is dominating the global hammertoe market, by end user as hospitals are rapidly adopting new technologies and procedures to provide adequate services. Hospitals are also spending about 10% of their annual budget on technology.


Global Hammertoe Market Share, by Region, 2017 (%)  Hammertoe Market      


Sources: MRFR Analysis


Regional Analysis


The global hammertoe market is growing steadily. In 2016, North America and Europe held more than half of the share of the global hammertoe market. Increasing investments in R&D and new product development are the key drivers for the market growth in these regions. The demand is higher in high-income countries, but the market is rapidly growing in developing and emerging economies, such as China and India. Rapidly changing technology is also affecting the healthcare sector. Health professionals and manufacturing companies are adopting changes to provide the best possible solutions to the market.


Based on region, the global hammertoe market is segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa. In 2016, North America held the largest market share and was the highest revenue generator in the global hammertoe market.


North America is a pioneer in the foot and ankle surgery and the largest market in the global hammertoe market. Due to the availability of top-class healthcare infrastructure, advanced medical facilities, and the rapid adoption of new products and treatments, the North American hammertoe market is growing continuously. Many top players are operating from this region, which is leading to innovation and new product developments. Some other factors, such as the availability of skilled health professionals, availability of products, high purchasing power, etc. also boost the growth of the market. According to the 2012 National Foot Health Assessment conducted by the NPD Group (formerly known as National Purchase Diary, Inc.) for the Institute for Preventive Foot Health, 3%of the US adults aged 21 and older (about 7 million people) have experienced hammertoe or claw toe.


Due to the increasing healthcare expenditure and rapidly developing healthcare sector, Asia-Pacific is expected to be the fastest-growing region in the global hammertoe market during the forecast period.


Key Players


The prominent players in the global hammertoe market are Stryker, Smith & Nephew, Zimmer Biomet Holdings, Extremity Medical LLC, Nextremity Solutions, Inc., Arrowhead Medical Device Technologies LLC, Wright Medical Group N.V., Nextremity Solutions, Inc., and BioPro.


The players operating in the global hammertoe market are focusing on product launches and expanding their global footprint by entering untapped markets.   


Market Segmentation


Global Hammertoe Market, by Type



  • Rigid

  • Flexible


Global Hammertoe Market, by Treatment & Diagnosis



  • Treatment

  • Diagnosis


Global Hammertoe Market, by End User



  • Hospitals & Clinics

  • Physiotherapy & Orthopedic Centers


Global Hammertoe Market, by Region



  • North America

    • US

    • Canada

    • Mexico





  • Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe





  • Asia-Pacific

    • China

    • India

    • Japan

    • Australia & New Zealand

    • Southeast Asia

    • Rest of Asia-Pacific





  • Rest of the World

    • Middle East

    • Africa

    • South America




Available Additional Customizations


Company Profiles of Key Regional Players



  • Instratek

  • Biomet, Inc.

  • Acumed


Intended Audience



  • Medical device manufacturers

  • Personal care industry

  • Retailers, distributors, and wholesalers

  • Governments, associations, and industrial bodies

  • Investors and trade experts



Frequently Asked Questions (FAQ) :


Hammertoe market projected to grow at approximately 10.8% CAGR during the assessment period (2020-2027).

The valuation of the global hammertoe market is estimated to increase to USD 288.6 MN by the end of 2023.

Growing R&D expenditure in the healthcare and government support, are major tailwinds pushing the growth of the global hammertoe market.

North America holds the largest share in the global hammertoe market, followed by Europe and the Asia Pacific, respectively.

Instratek (U.S.), Acumed (U.S.), BioPro (U.S.), Biomet, Inc. (U.S.), Stryker Corporation (U.S.), Nextremity Solutions, Inc. (U.S.), Arrowhead Medical Device Technologies LLC (U.S.), Smith & Nephew plc (U.S.), Extremity Medical LLC (U.S.), and Wright Medical Group N.V. (U.S.), are some of the top players operating in the global hammertoe market.

Market Overview


The Global Hammertoe Market touched a valuation of 172.51 USD million in 2018 and is likely to garner 288.61 USD million by the end of 2023. The global market is presumed to demonstrate 10.8% CAGR during the forecast period (2018-2023) owing to the rising prevalence of arthritis, asserts Market Research Future (MRFR). Hammertoe can be defined as a feet disorder where the feet bends permanently and occurs due to an imbalance in the muscles and the ligaments. It usually occurs while wearing narrow shoes or small-size shoes. Hammertoe can also occur since birth in some individuals.


Arthritis is one of the most common joint related problems which occurs due to increasing age and osteoporosis and is one of the major reasons for hammertoe. With the rising prevalence of arthritis among the population, the global hammertoe market is considered to foster during the appraisal period. As per the Centers for Disease Control and Prevention, around 54.4 million of the total population, on February 2018, has been diagnosed with arthritis, in which 18.1% were men and 23.4% were women. The growing expenditure on research and development activities in the healthcare industry is further considered to contribute to the global hammertoe market. Moreover, as the bones related and hammertoe problems are increasing across the world, the need for advanced healthcare services is also increasing. For instance, the U.S. has increased their investment by 13.3% in healthcare research and development from 2013 to 2015. Thus, investments in the healthcare sector by the private and government sectors are highly contributing to the market growth.


Meanwhile, risk of infections associated during the hospital stay and surgical treatments are estimated to dampen the market in the coming years. During surgical treatments, there is a risk of cross-contamination by the surgical instruments during a hospital stay or getting bacterial infections. For instance, as per the National Center for Biotechnology Information, the prevalence of surgical site infection during surgical procedures is 0.1 to 50%, which highly hampers the market growth.


Global Hammertoe Market: Segmental Analysis


The global hammertoe market has been segmented on the basis of type, treatment and diagnosis, end-user, and region.


By mode of type, the global hammertoe market has been segmented into flexible and rigid. Flexible hammertoes cause irritation and pain that leads to the development of calluses and corns. On the other hand, the rigid hammertoes lose their flexibility, and the joints are immovable. Among these, the rigid hammertoe segment is projected to exhibit a higher CAGR than its counterpart.


By treatment, surgery is expected to generate significant revenue, while in diagnosis, the physical examination segment has a larger share of the hammer toe market. Among these, the surgery segment is considered to lead the global hammertoe market owing to the rising geriatric population, increasing incidences of arthritis, and high adoption of surgical procedures for treating hammertoe. Companies such as Stryker have developed implants as a dependable treatment option which can alleviate the sensations caused by hammertoe.


The hospital segment dominates the global hammertoe market due to the rapid adoption of new procedures and technologies to offer effective services. It can be the biggest end-user for the market owing to availability of numerous treatment options.


Regional Insights


The North American region holds the largest market share in the global hammertoe market and a pioneer in foot and ankle surgery. The growth is attributed to the availability of top-class healthcare infrastructure, advanced medical facilities, and rapid adoption of new products and treatments. With the availability of skilled health professionals, availability of products, and high purchasing power, the region is likely to expand. Moreover, top players operating from this region are leading to innovation and new product developments which is further influencing the market growth.


Asia-Pacific is the fastest growing region and is presumed to maintain the same owing to the rapidly developing economy, increasing awareness of new products and treatments, and changing healthcare sector. Moreover, several initiatives have been taken by the government to improve public health. With a growing geriatric population coupled with accident cases, the market is likely to foster in the coming years.


Europe holds the second position owing to the advanced healthcare technology and rapid adoption of new devices. Western European countries like the France, Germany, and the U.K., are holding the maximum share, thereby dominating the European hammertoe market.


Competitive Dashboard


The prominent players operating the global hammertoe market are Wright Medical Group N.V. (Memphis, TN), Stryker (U.S), Nextremity Solutions Inc. (U.S), BioPro (Michigan), Arrowhead Medical Device Technologies LLC (Tennessee), Extremity Medical LLC (U.S), Smith & Nephew (U.K), and Zimmer Biomet Holdings (U.S).

1 Report Prologue

2 Market Introduction

2.1 Scope Of Study 15

2.2 Research Objective 15

2.3 List Of Assumptions 15

3 Research Methodology

3.1 Research Process 18

3.2 Primary Research 19

3.3 Secondary Research 20

3.4 Market Size Estimation 21

4 Market Dynamics

4.1 Introduction 23

4.2 Drivers 23

4.2.1 Increasing Prevalence Of Arthritis Among The Population 23

4.2.2 Growing R&D Expenditure In The Healthcare Industry 23

4.3 Restraints 23

4.3.1 Risk Of Infections During Surgical Treatments And Hospital Stay 23

4.4 Opportunity 23

4.4.1 Technological Advancements In Hammertoe Products 23

5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis 25

5.1.1 Introduction 25

5.1.2 Bargaining Power Of Suppliers 25

5.1.3 Bargaining Power Of Buyers 26

5.1.4 Threat Of New Entrants 26

5.1.5 Threat Of Substitutes 26

5.1.6 Intensity Of Rivalry 26

5.2 Value Chain Analysis 27

5.2.1 Introduction 27

5.2.2 Primary Activities 27

5.2.2.1 Inbound Logistics 27

5.2.2.2 Production And Operation 27

5.2.2.3 Outbound Logistics 27

5.2.3 Secondary Activities 27

6 Hammertoe Market, By Type

6.1 Introduction 29

6.2 Rigid 30

6.3 Flexible 30

7 Hammertoe Market, By Treatment & Diagnosis

7.1 Introduction 32

7.2 Treatment 33

7.3 Diagnosis 33

8 Hammertoe Market, By End User

8.1 Introduction 35

8.2 Hospitals & Clinics 36

8.3 Physiotherapy & Orthopedic Centers 36

9 Global Hammertoe Market, By Region

9.1 Introduction 38

9.2 Americas 40

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.2.1 North America 42

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.2.1.1 US 44

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.2.1.2 Canada 45

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.2.2 South America 47

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.3 Europe 49

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.3.1 Western Europe 51

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.3.1.1 Germany 53

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.3.1.2 UK 54

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.3.1.3 France 56

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.3.1.4 Italy 57

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.3.1.5 Spain 59

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.3.1.6 Rest Of Western Europe 60

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.3.2 Eastern Europe 62

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.4 Asia-Pacific 64

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.4.1 Japan 66

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.4.2 China 67

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.4.3 India 69

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.4.4 Australia 70

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.4.5 South Korea 72

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.4.6 Rest Of Asia-Pacific 73

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.5 Middle East & Africa 75

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.5.1 Middle East 77

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

9.5.2 Africa 78

Hammertoe Market, By Type

Hammertoe Market, By Treatment & Diagnosis

Hammertoe Market, By End User

10 Competitive Landscape

10.1 Introduction 81

11 Company Profiles

11.1 Stryker 83

11.1.1 Company Overview 83

11.1.2 Financial Overview 83

11.1.3 Products/Services Offered 83

11.1.4 SWOT Analysis 84

11.1.5 Key Developments 84

11.1.6 Key Strategies 84

11.2 Smith & Nephew 85

11.2.1 Company Overview 85

11.2.2 Financial Overview 85

11.2.3 Products/Services Offered 86

11.2.4 Key Developments 86

11.2.5 SWOT Analysis 86

11.2.6 Key Strategies 86

11.3 Zimmer Biomet Holdings 87

11.3.1 Company Overview 87

11.3.2 Financial Overview 87

11.3.3 Products/Services Offered 87

11.3.4 Key Developments 88

11.3.5 SWOT Analysis 88

11.3.6 Key Strategies 88

11.4 Extremity Medical LLC 89

11.4.1 Company Overview 89

11.4.2 Financial Overview 89

11.4.3 Products/Services Offered 89

11.4.4 Key Developments 89

11.4.5 SWOT Analysis 90

11.4.6 Key Strategies 90

11.5 Nextremity Solutions, Inc. 91

11.5.1 Company Overview 91

11.5.2 Financial Overview 91

11.5.3 Products/Services Offered 91

11.5.4 Key Developments 91

11.5.5 SWOT Analysis 91

11.5.6 Key Strategies 91

11.6 Arrowhead Medical Device Technologies LLC 92

11.6.1 Company Overview 92

11.6.2 Financial Overview 92

11.6.3 Products/Services Offered 92

11.6.4 Key Developments 92

11.6.5 SWOT Analysis 92

11.6.6 Key Strategies 92

11.7 Wright Medical Group N.V. 93

11.7.1 Company Overview 93

11.7.2 Financial Overview 93

11.7.3 Products/Services Offered 94

11.7.4 Key Developments 94

11.7.5 SWOT Analysis 94

11.7.6 Key Strategies 94

11.8 Nextremity Solutions, Inc. 95

11.8.1 Company Overview 95

11.8.2 Financial Overview 95

11.8.3 Products/Services Offered 95

11.8.4 Key Developments 95

11.8.5 SWOT Analysis 95

11.8.6 Key Strategies 96

11.9 BioPro 97

11.9.1 Company Overview 97

11.9.2 Financial Overview 97

11.9.3 Products/Services Offered 97

11.9.4 Key Developments 97

11.9.5 SWOT Analysis 97

11.9.6 Key Strategies 98

12 Appendix

12.1 Discussion Blue Print 100

13 List Of Tables

TABLE 1 LIST OF ASSUMPTIONS 15

TABLE 2 PRIMARY INTERVIEWS 18

TABLE 3 GLOBAL HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 29

TABLE 4 GLOBAL HAMMERTOE MARKET FOR, RIGID TYPE 2020–2027 (USD MILLION) 30

TABLE 5 GLOBAL HAMMERTOE MARKET FOR, FLEXIBLE TYPE 2020–2027 (USD MILLION) 30

TABLE 6 GLOBAL HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 32

TABLE 7 GLOBAL HAMMERTOE MARKET FOR, TREATMENT 2020–2027 (USD MILLION) 33

TABLE 8 GLOBAL HAMMERTOE MARKET FOR, DIAGNOSIS 2020–2027 (USD MILLION) 33

TABLE 9 GLOBAL HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 35

TABLE 10 GLOBAL HAMMERTOE MARKET FOR, HOSPITALS & CLINICS 2020–2027 (USD MILLION) 36

TABLE 11 GLOBAL HAMMERTOE MARKET FOR, PHYSIOTHERAPY AND ORTHOPEDIC CENTERS 2020–2027 (USD MILLION) 36

TABLE 12 GLOBAL HAMMERTOE MARKET, BY REGION 2020–2027 (USD MILLION) 39

TABLE 13 AMERICAS HAMMERTOE MARKET, BY REGION 2020–2027 (USD MILLION) 40

TABLE 14 AMAERICAS HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 40

TABLE 15 AMAERICAS HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 41

TABLE 16 AMAERICAS HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 41

TABLE 17 AMAERICAS HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 41

TABLE 18 NOTH AMERICA HAMMERTOE MARKET, BY COUNTRY 2020–2027 (USD MILLION) 42

TABLE 19 NOTH AMERICA HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 42

TABLE 20 NOTH AMERICA HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 42

TABLE 21 NOTH AMERICA HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 43

TABLE 22 NOTH AMERICA HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 43

TABLE 23 US HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 44

TABLE 24 US HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 44

TABLE 25 US HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 44

TABLE 26 US HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 45

TABLE 27 CANADA HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 45

TABLE 28 CANADA HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 45

TABLE 29 CANADA HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 46

TABLE 30 CANADA HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 46

TABLE 31 SOUTH AMERICA HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 47

TABLE 32 SOUTH AMERICA HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 47

TABLE 33 SOUTH AMERICA HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 47

TABLE 34 SOUTH AMERICA HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 48

TABLE 35 EUROPE HAMMERTOE MARKET, BY REGION 2020–2027 (USD MILLION) 49

TABLE 36 EUROPE HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 49

TABLE 37 EUROPE HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 49

TABLE 38 EUROPE HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 50

TABLE 39 EUROPE HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 50

TABLE 40 WESTERN EUROPE HAMMERTOE MARKET, BY REGION 2020–2027 (USD MILLION) 51

TABLE 41 WESTERN EUROPE HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 51

TABLE 42 WESTERN EUROPE HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 52

TABLE 43 WESTERN EUROPE HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 52

TABLE 44 WESTERN EUROPE HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 52

TABLE 45 GERMANY HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 53

TABLE 46 GERMANY HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 53

TABLE 47 GERMANY HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 53

TABLE 48 GERMANY HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 54

TABLE 49 UK HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 54

TABLE 50 UK HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 54

TABLE 51 UK HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 55

TABLE 52 UK HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 55

TABLE 53 FRANCE HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 56

TABLE 54 FRANCE HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 56

TABLE 55 FRANCE HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 56

TABLE 56 FRANCE HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 57

TABLE 57 ITALY HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 57

TABLE 58 ITALY HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 57

TABLE 59 ITALY HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 58

TABLE 60 ITALY HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 58

TABLE 61 SPAIN HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 59

TABLE 62 SPAIN HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 59

TABLE 63 SPAIN HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 59

TABLE 64 SPAIN HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 60

TABLE 65 REST OF WESTERN EUROPE HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 60

TABLE 66 REST OF WESTERN EUROPE HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 60

TABLE 67 REST OF WESTERN EUROPE HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 61

TABLE 68 REST OF WESTERN EUROPE HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 61

TABLE 69 EASTERN EUROPE HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 62

TABLE 70 EASTERN EUROPE HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 62

TABLE 71 EASTERN EUROPE HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 62

TABLE 72 EASTERN EUROPE HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 63

TABLE 73 ASIA-PACIFIC HAMMERTOE MARKET, BY COUNTRY 2020–2027 (USD MILLION) 64

TABLE 74 ASIA-PACIFIC HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 64

TABLE 75 ASIA-PACIFIC HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 65

TABLE 76 ASIA-PACIFIC HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 65

TABLE 77 ASIA-PACIFIC HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 65

TABLE 78 JAPAN HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 66

TABLE 79 JAPAN HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 66

TABLE 80 JAPAN HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 66

TABLE 81 JAPAN HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 67

TABLE 82 CHINA HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 67

TABLE 83 CHINA HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 67

TABLE 84 CHINA HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 68

TABLE 85 CHINA HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 68

TABLE 86 INDIA HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 69

TABLE 87 INDIA HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 69

TABLE 88 INDIA HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 69

TABLE 89 INDIA HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 70

TABLE 90 AUSTRALIA HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 70

TABLE 91 AUSTRALIA HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 70

TABLE 92 AUSTRALIA HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 71

TABLE 93 AUSTRALIA HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 71

TABLE 94 SOUTH KOREA HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 72

TABLE 95 SOUTH KOREA HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 72

TABLE 96 SOUTH KOREA HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 72

TABLE 97 SOUTH KOREA HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 73

TABLE 98 REST OF ASIA-PACIFIC HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 73

TABLE 99 REST OF ASIA-PACIFIC HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 73

TABLE 100 REST OF ASIA-PACIFIC HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 74

TABLE 101 REST OF ASIA-PACIFIC HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 74

TABLE 102 MIDDLE EAST & AFRICA HAMMERTOE MARKET, BY REGION 2020–2027 (USD MILLION) 75

TABLE 103 MIDDLE EAST & AFRICA HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 75

TABLE 104 MIDDLE EAST & AFRICA HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 75

TABLE 105 MIDDLE EAST & AFRICA HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 76

TABLE 106 MIDDLE EAST & AFRICA HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 76

TABLE 107 MIDDLE EAST HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 77

TABLE 108 MIDDLE EAST HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 77

TABLE 109 MIDDLE EAST HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 77

TABLE 110 MIDDLE EAST HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 78

TABLE 111 AFRICA HAMMERTOE MARKET, BY TYPE 2020–2027 (USD MILLION) 78

TABLE 112 AFRICA HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020–2027 (USD MILLION) 78

TABLE 113 AFRICA HAMMERTOE MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 79

TABLE 114 AFRICA HAMMERTOE MARKET, BY END USER 2020–2027 (USD MILLION) 79

TABLE 115 TOP PLAYERS IN THE GLOBAL HAMMERTOE MARKET 81

14 List Of Figures

FIGURE 1 GLOBAL HAMMERTOE MARKET: MARKET STRUCTURE 16

FIGURE 2 RESEARCH PROCESS 18

FIGURE 3 TOP-DOWN AND BOTTOM-UP APPROACH 21

FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL HAMMERTOE MARKET 25

FIGURE 5 VALUE CHAIN 27

FIGURE 6 GLOBAL HAMMERTOE MARKET, BY TYPE 2020 & 2027 (USD MILLION) 29

FIGURE 7 GLOBAL HAMMERTOE MARKET, BY TREATMENT & DIAGNOSIS 2020 & 2027 (USD MILLION) 33

FIGURE 8 GLOBAL HAMMERTOE MARKET, BY END USER 2020 & 2027 (USD MILLION) 35

FIGURE 9 GLOBAL HAMMERTOE MARKET SHARE BY, REGION 2020 (%) 39

FIGURE 10 AMERICAS HAMMERTOE MARKET SHARE BY, REGION 2020 (%) 40

FIGURE 11 NOTH AMERICA HAMMERTOE MARKET SHARE BY, COUNTRY 2020 (%) 42

FIGURE 12 EUROPE HAMMERTOE MARKET SHARE BY, REGION 2020 (%) 49

FIGURE 13 WESTERN EUROPE HAMMERTOE MARKET SHARE BY, REGION 2020 (%) 51

FIGURE 14 ASIA-PACIFIC HAMMERTOE MARKET SHARE BY, COUNTRY 2020 (%) 64

FIGURE 15 MIDDLE EAST & AFRICA HAMMERTOE MARKET SHARE BY, REGION 2020 (%) 75

Competitive landscape:


The Global Hammertoe Market is characterized by the presence of many global, regional, and local vendors. The market is competitive with all players competing to gain a presence in the market. Intense competition, rapid advances in technology, frequent changes in government policies, and regulations are key factors that confront market growth. The manufacturers compete based on cost, quality, and reliability. It is decisive for manufacturers to provide cost-efficient and high-quality products to survive and succeed in an intensely competitive market environment.


The growth of market players is dependent on market conditions, government support, and industry development. Thus, manufacturers should focus on expanding geographically and improving their products. They primarily focus on the development of novel products. Although international players are dominating the market, regional and foreign players with small market shares also have a presence. The international players are likely to strengthen their presence worldwide through acquisitions during the forecast period. It has also been forecast that the improvement of the global economic scenario combined with efforts to enhance the infrastructure in emerging nations, is fuelling the market growth, thereby making it an ideal time for new products and to increase the global market share.


The major players with better technical and financial resources can develop innovative products. Further, research and development will play a major role in the development of a player in the market. Therefore, manufacturers must develop new technologies and stay abreast of emerging technologies that could affect the continuing competitiveness of their products and services in the market. The major players in the market are Stryker, Nextremity Solutions, Inc., Zimmer Biomet Holdings, Wright Medical Group N.V.


Intended Audience:



  • Medical Device Manufacturers

  • Suppliers and Distributors

  • Advanced Surgical Trainees

  • Governmental Agency

  • Research Institutes and Academic Centers

  • Market Research and Consulting

  • End-user sectors